Feb 10, 2021 10:00am EST 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits
Jan 28, 2021 10:00am EST 22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District
Jan 26, 2021 12:00pm EST The Buffalo News Op-ed: 22nd Century CEO Urges FDA to Proceed with Plan to Limit Nicotine Levels in Cigarettes
Jan 19, 2021 7:30am EST Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century Group
Jan 11, 2021 12:00pm EST 22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content Cigarettes
Dec 17, 2020 10:10am EST 22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable Cannabinoids
Dec 08, 2020 10:00am EST 22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported Research
Nov 24, 2020 11:00am EST 22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article
Nov 18, 2020 10:00am EST 22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
